Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study
18h agoen
From the article
Conditions : Overactive Bladder Interventions : Procedure: Intravesical Botulinum Toxin A (100U); Procedure: Intravesical Platelet-Rich Plasma Sponsors : Mahmoud Mohamed Farag Ali Active, not recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Growing BPH treatment options offer short-term relief but lack long-term data
This article examines the growing array of treatment options for benign prostatic hyperplasia (BPH), including steam therapy, permanent impl
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·1d ago
Harnessing Nature's Power: The Rise of PRP Therapy in the Pursuit of Natural Beauty
ltcnews.com·2y ago
Pour la toute première fois, des chercheurs réalisent une cartographie des nerfs du clitoris et elle révèle une complexité insoupçonnée
Science et vie·1d ago
Platelet-Rich Plasma Therapy: Unveiling the Benefits for Regenerative Medicine
ltcnews.com·1y ago

New plasma proteomics model improves thrombosis risk prediction in cancer patients and identifies IL-17-driven endothelial activation as therapeutic target
This article presents research by Karagkouni and colleagues who developed a new cancer-associated venous thromboembolism (VTE) prediction mo

Comments
Sign in to join the conversation.
No comments yet. Be the first.